Tongxinluo Capsule in Ischemic Stroke Patients(TISS)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2007 participants.

Also called NCT01919671

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,007 participants (enrolled count) (from the registry)
Sponsor
  • Yongjun Wang Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01919671
Other papers using this trial's data
  • Tongxinluo and Functional Outcomes Among Patients With Acute Ischemic Stroke: A Randomized Clinical Trial JAMA network open, 2024-09-03 DOI, PubMed 39325453, PMC11428006 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01919671. Randomized; quadruple masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tongxinluo Capsule in Ischemic Stroke Patients(TISS)
Intervention (Drug)
Tongxinluo capsule
Intervention (Drug)
placebo capsule
Lead sponsor
yongjun wang (class: other government)

Record details

Record id
cardio:ct-nct01919671
Content hash
465707781c9e2e45113ba8ca21621286e0983cab46d5c8f661adbbff8037ee8b